Bausch Health Companies Inc
SWB:BVF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Bausch Health Companies Inc
SWB:BVF
|
CA |
|
Aritzia Inc
F:280
|
CA |
|
Pearl Global Industries Ltd
NSE:PGIL
|
IN |
|
G
|
Glenmark Pharmaceuticals Ltd
BSE:532296
|
IN |
|
BayWa AG
LSE:0AH6
|
DE |
|
Dynamatic Technologies Ltd
NSE:DYNAMATECH
|
IN |
Wall St Price Targets
BVF Price Targets Summary
Bausch Health Companies Inc
According to Wall Street analysts, the average 1-year price target for BVF is 6.203 EUR with a low forecast of 6.142 EUR and a high forecast of 6.385 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BVF's stock price target?
Price Target
6.203
EUR
According to Wall Street analysts, the average 1-year price target for BVF is 6.203 EUR with a low forecast of 6.142 EUR and a high forecast of 6.385 EUR.
What is the Revenue forecast for Bausch Health Companies Inc?
Projected CAGR
0%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 7 years is 0%.
What is the Operating Income forecast for Bausch Health Companies Inc?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Operating Income has been 10%. The projected CAGR for the next 7 years is 5%.
What is the Net Income forecast for Bausch Health Companies Inc?
Projected CAGR
39%
The compound annual growth rate for Net Income over the next 7 years is 39%.
